National Drug Strategy
National Drug Strategy

National pharmacotherapy policy for people dependent on opioids

Print page  Decrease text size  Increase text size

These guidelines have been prepared to provide a broad policy context and framework for state and territory policies and guidelines that are concerned with the treatment of heroin dependence with methadone, buprenorphine and naltrexone.

Published by the Australian Government Department of Health and Ageing for National Drug Strategy
January 2007

For clinical matters associated with pharmacotherapy treatments, please refer to respective national clinical guidelines.

PDF printable version of National pharmacotherapy policy for people dependent on opioids (PDF 499 KB)

Page currency, Latest update: January, 2007